Wedbush Securities Inc. cut its holdings in shares of Cooper Companies Inc (NYSE:COO) by 10.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,640 shares of the medical device company’s stock after selling 185 shares during the quarter. Wedbush Securities Inc.’s holdings in Cooper Companies were worth $486,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Essex Savings Bank acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $25,000. Certified Advisory Corp acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $25,000. Executive Wealth Management LLC acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $34,000. Financial Gravity Companies Inc. acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $46,000. Finally, Rehmann Capital Advisory Group lifted its holdings in shares of Cooper Companies by 24.3% during the fourth quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock worth $56,000 after buying an additional 43 shares during the last quarter.

In other Cooper Companies news, Director Gary S. Petersmeyer sold 799 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $286.88, for a total value of $229,217.12. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Agostino Ricupati sold 2,400 shares of the company’s stock in a transaction on Friday, March 29th. The shares were sold at an average price of $296.13, for a total value of $710,712.00. Following the completion of the sale, the senior vice president now owns 400 shares in the company, valued at $118,452. The disclosure for this sale can be found here. Insiders sold 87,030 shares of company stock valued at $25,461,465 over the last 90 days. 1.70% of the stock is currently owned by corporate insiders.

A number of brokerages have recently commented on COO. Raymond James upped their price target on Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a report on Wednesday, March 6th. BMO Capital Markets upped their price target on Cooper Companies from $306.00 to $320.00 and gave the stock an “outperform” rating in a report on Wednesday, March 6th. Stephens upped their price target on Cooper Companies from $305.00 to $320.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. KeyCorp upped their target price on Cooper Companies from $296.00 to $314.00 and gave the company an “overweight” rating in a research note on Wednesday, March 6th. Finally, Piper Jaffray Companies restated an “overweight” rating and issued a $325.00 target price on shares of Cooper Companies in a research note on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $307.90.

Shares of NYSE COO opened at $284.31 on Tuesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.27 and a quick ratio of 0.75. The firm has a market capitalization of $14.09 billion, a P/E ratio of 24.72, a PEG ratio of 2.18 and a beta of 0.88. Cooper Companies Inc has a one year low of $220.90 and a one year high of $302.36.

Cooper Companies (NYSE:COO) last issued its earnings results on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.38. The business had revenue of $628.10 million during the quarter, compared to analyst estimates of $618.50 million. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. Equities analysts anticipate that Cooper Companies Inc will post 12.01 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Cooper Companies Inc (COO) Shares Sold by Wedbush Securities Inc.” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/cooper-companies-inc-coo-shares-sold-by-wedbush-securities-inc/2982230.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Liquidity

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.